Agios Pharmaceuticals Inc (AGIO)

Agios Pharmaceuticals Inc (AGIO) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	15.29% 8.189	7.103	7.399	6.712	5.609
Cost Of Revenue	7.00% 0.627	0.586	0.633	1.108	0.554
Gross Profit	16.03% 7.562	6.517	6.766	5.604	5.055
Operating Expenses	11.67% 99.63	112.79	107.66	99.30	95.67
Benefits Costs and Expenses	35.52% 100.26	73.98	108.30	100.41	96.22
Costs And Expenses	11.57% 100.26	113.38	108.30	100.41	96.22
Operating Income/Loss	13.37% -92.07	-106.28	-100.90	-93.70	-90.61
Income/Loss From Continuing Operations Before Tax	37.67% -92.07	-66.88	-100.90	-83.81	-81.02
Income/Loss From Continuing Operations After Tax	15.00% -81.55	-95.94	-91.32	-83.81	-81.02
Net Income/Loss	15.00% -81.55	-95.94	-91.32	-83.81	-81.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	61,373% 56.38	0.0917	55.80	55.60	55.27
Diluted Average Shares	61,373% 56.38	0.0917	55.80	55.60	55.27
Basic Earnings Per Share	15.70% -1.45	-1.72	-1.64	-1.51	-1.47
Diluted Earnings Per Share	15.70% -1.45	-1.72	-1.64	-1.51	-1.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-